Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP

被引:99
|
作者
Hetherington, SL [1 ]
Singh, RK [1 ]
Lodwick, D [1 ]
Thompson, JR [1 ]
Goodall, AH [1 ]
Samani, NJ [1 ]
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England
关键词
platelets; thrombosis; genes; receptors; adenosine diphosphate;
D O I
10.1161/01.ATV.0000148708.44691.27
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The platelet ADP receptors P2Y1 and P2Y12 play a pivotal role in platelet aggregation. There is marked interindividual variation in platelet response to ADP. We studied whether genetic variants in the P2Y1 or P2Y12 genes affect platelet response to ADP. Methods and Results - The P2Y1 and P2Y12 genes were screened for polymorphisms. Associations between selected polymorphisms and the platelet response to ADP (0.1, 1.0, and 10 mumol/L), assessed by whole blood flow cytometric measurement of fibrinogen binding to activated glycoprotein IIb-IIIa, were then determined in 200 subjects. Five polymorphisms were found in the P2Y1 gene and 11 in the P2Y12 gene. All polymorphisms were silent. A P2Y1 gene dimorphism, 1622A>G, was associated with a significant (P=0.007) effect on platelet ADP response, with a greater response in carriers of the G allele (frequency 0.15). The effect was seen at all concentrations of ADP but greatest at 0.1 mumol/L ADP, where the response in GG homozygotes was on average 130% higher than that seen in AA homozygotes (P=0.006). Conclusions - A common genetic variant at the P2Y1 locus is associated with platelet reactivity to ADP. This genotype effect partly explains the interindividual variation in platelet response to ADP and may have clinical implications with regard to thrombotic risk.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 50 条
  • [21] The roles of the platelet ADP receptors P2Y1 and P2Y12 in a thromboembolic reaction in vivo
    van Gestel, MA
    Heemskerk, JWM
    Slaaf, DW
    Heijnen, VVT
    Egbrink, MGAO
    FASEB JOURNAL, 2002, 16 (04): : A131 - A131
  • [22] Molecular basis for ADP-induced platelet activation II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
    Jin, JG
    Daniel, JL
    Kunapuli, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) : 2030 - 2034
  • [23] PIT blocks P2Y1 receptor signaling without affecting ADP binding
    Gao, ZG
    Mamedova, LK
    Jacobson, KA
    FASEB JOURNAL, 2004, 18 (04): : A584 - A584
  • [24] Components of traditional Chinese medicine inhibit platelet aggregation by blocking ADP receptor subtypes P2Y1 and P2Y12
    Xiao-liang WANG
    Yi-ying LI
    Hong-yan YANG
    Shaofeng XU
    Ling WANG
    中国药理学与毒理学杂志, 2015, 29(S1) (S1) : 28 - 29
  • [25] Partial aggregation at high doses of ADP in P2Y1 knockout mice: The ADP adenylate-cyclase-linked receptor is not P2Y2.
    Fabre, JEM
    Nguyen, MT
    Cressman, V
    Koller, BH
    BLOOD, 1999, 94 (10) : 618A - 618A
  • [26] The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.
    Léon, C
    Cattaneo, M
    Lecchi, A
    Vial, C
    Hechler, B
    Ohlmann, P
    Cazenave, JP
    Gachet, C
    BLOOD, 1998, 92 (10) : 65B - 65B
  • [27] Desensitization of the platelet aggregation response to ADP:: Differential down-regulation of the P2Y1 and P2cyc receptors
    Baurand, A
    Eckly, A
    Bari, N
    Léon, C
    Hechler, B
    Cazenave, JP
    Gachet, C
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (03) : 484 - 491
  • [28] A comparison of different regression models for the quantitative analysis of the combined effect of P2Y12 and P2Y1 receptor antagonists??????? on ADP-induced platelet activation
    Watala, Cezary
    Wzorek, Joanna
    Palma, Agnieszka
    Boncler, Magdalena
    THROMBOSIS RESEARCH, 2022, 211 : 88 - 97
  • [29] A HAPLOTYPE OF P2Y12 GENE ASSOCIATED WITH THE INCREASED RESPONSES TO ADP-INDUCED PLATELET AGGREGATION
    Lee, S.
    Park, B.
    Cho, D.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S18 - S18
  • [30] Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation
    Chang, H.
    Yanachkov, I. B.
    Dix, E. J.
    Li, Y. F.
    Barnard, M. R.
    Wright, G. E.
    Michelson, A. D.
    Frelinger, A. L., III
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (12) : 2573 - 2580